HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Tsuboi Selected Research

Levodopa (L Dopa)

6/2019Clinical correlates of repetitive speech disorders in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Tsuboi Research Topics

Disease

18Parkinson Disease (Parkinson's Disease)
06/2022 - 05/2015
14Schizophrenia (Dementia Praecox)
10/2022 - 06/2011
6Major Depressive Disorder (Major Depressive Disorders)
03/2022 - 01/2017
6Dystonia (Limb Dystonia)
01/2021 - 01/2019
4Essential Tremor (Essential Tremors)
09/2021 - 10/2020
4Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 01/2020
4Speech Disorders (Cluttering)
01/2020 - 05/2015
3Mania (Manias)
01/2022 - 11/2020
3Tremor (Tremors)
01/2021 - 01/2020
3Dysarthria (Spastic Dysarthria)
01/2020 - 12/2017
3Voice Disorders (Voice Disturbances)
12/2017 - 08/2015
2Treatment-Resistant Schizophrenia
10/2022 - 01/2022
2Pain (Aches)
06/2022 - 05/2020
2Mental Disorders (Mental Disorder)
01/2022 - 01/2021
2Psychotic Disorders (Schizoaffective Disorder)
01/2021 - 08/2016
2Sudden Infant Death (SID)
01/2021 - 01/2019
2Demyelinating Diseases (Demyelinating Disease)
01/2020 - 12/2016
2Stuttering (Stammering)
06/2019 - 12/2017
2Disease Progression
01/2018 - 01/2013
2Hypersensitivity (Allergy)
01/2013 - 01/2010
2Insulinoma
04/2006 - 04/2003
1Fatigue
06/2022
1COVID-19
06/2022
1Myocarditis (Carditis)
06/2022
1Pericarditis
06/2022
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022
1Dyskinesias (Dyskinesia)
01/2021
1Body Weight (Weight, Body)
11/2020
1Prodromal Symptoms
05/2020
1Torticollis (Wryneck)
05/2020
1Dystonia musculorum deformans type 1
01/2020
1Brain Diseases (Brain Disorder)
01/2020
1Hemorrhage
01/2020
1Substance-Related Disorders (Drug Abuse)
01/2020
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
12/2019
1Mood Disorders (Mood Disorder)
10/2019
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018
1X-Linked Bulbo-Spinal Atrophy
01/2018
1Autism Spectrum Disorder
01/2018
1Multiple Sclerosis
12/2016
1Pathologic Complete Response
12/2016
1Darier Disease (Darier's Disease)
08/2016
1Hyperprolactinemia
08/2013
1Cataract (Cataracts)
10/2012
1Uveitis
10/2012
1Dental Caries (Decay, Dental)
08/2012

Drug/Important Bio-Agent (IBA)

9Antipsychotic Agents (Antipsychotics)IBA
10/2022 - 06/2011
6Antidepressive Agents (Antidepressants)IBA
01/2022 - 01/2020
4Risperidone (Risperdal Consta)FDA LinkGeneric
09/2021 - 04/2012
4Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2002
3Cholinergic Antagonists (Anticholinergics)IBA
01/2022 - 01/2011
3Olanzapine (Zyprexa)FDA Link
09/2021 - 04/2012
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
08/2013 - 04/2012
2Clozapine (Clozaril)FDA LinkGeneric
10/2022 - 01/2022
2Hypnotics and Sedatives (Sedatives)IBA
01/2022 - 09/2021
2Anti-Anxiety Agents (Anxiolytics)IBA
01/2022 - 09/2021
2CalciumIBA
01/2021 - 08/2016
2LithiumIBA
11/2020 - 01/2020
2Dopamine (Intropin)FDA LinkGeneric
12/2019 - 05/2015
2Biological ProductsIBA
01/2018 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2013
2enhanced green fluorescent proteinIBA
04/2006 - 04/2003
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2006 - 04/2003
1Monoamine Oxidase (MAO)IBA
06/2022
1VaccinesIBA
06/2022
1N-acetyltryptophanamide (NATA)IBA
03/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2022
1SDMIBA
01/2022
1blonanserinIBA
09/2021
1Quetiapine Fumarate (Seroquel)FDA Link
09/2021
1Aripiprazole (Abilify)FDA Link
09/2021
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2021
1Carbamazepine (Tegretol)FDA LinkGeneric
11/2020
1Valproic Acid (Depakote)FDA LinkGeneric
11/2020
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2020
1LDL CholesterolIBA
05/2020
1Hemoglobins (Hemoglobin)IBA
05/2020
1N-acetyltalosaminuronic acid (NAT)IBA
05/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1SteroidsIBA
01/2020
1Levodopa (L Dopa)FDA LinkGeneric
06/2019
1CreatinineIBA
01/2018
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2017
1Fingolimod Hydrochloride (FTY720)FDA Link
12/2016
1Initiator Codon (Start Codon)IBA
08/2016
1Codon (Codons)IBA
08/2016
1Adenosine Triphosphatases (ATPase)IBA
08/2016
1ProlactinIBA
08/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1Hormones (Hormone)IBA
01/2013
1Sirolimus (Rapamycin)FDA Link
10/2012

Therapy/Procedure

25Deep Brain Stimulation
12/2021 - 05/2015
5Therapeutics
01/2020 - 12/2016
3Polypharmacy
03/2022 - 01/2021
2Activities of Daily Living (ADL)
10/2020 - 06/2019
1Drug Therapy (Chemotherapy)
03/2022
1Occupational Therapy (Therapy, Occupational)
01/2021
1Length of Stay
01/2020
1Oral Diagnosis (Oral Examination)
08/2012
1Injections
08/2012